{"Exaggerate": "The claim exaggerates the extent to which drug prices are coming down under the Trump administration. The expert's verdict states that while there has been some decrease in drug prices, the most recent data shows a slight uptick in prices.", "Understate": "There is no evidence of understatement bias in the claim.", "Lack enough support": "The claim lacks enough support as it does not provide specific evidence or data to back up the statement that drug prices are coming down.", "Problematic assumption": "The claim assumes that the decrease in drug prices is solely due to the Trump administration's efforts, without considering other factors or alternative explanations.", "Exist alternative explanation": "The expert's verdict suggests that there are alternative explanations for the decrease in drug prices, such as changes in list prices versus net prices, the impact of rebates, and the limited coverage of prescription data.", "Contradict fact": "The claim contradicts the fact that the most recent data shows a slight increase in drug prices, rather than a significant decrease as claimed.", "Falters at times": "There is no evidence of the claim faltering at times bias in the provided information."}